First Washington Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.91M Sell
8,602
-25
-0.3% -$25.3K 2.24% 14
2025
Q4
$9.27M Sell
8,627
-77
-0.9% -$73.6K 2.4% 9
2025
Q3
$6.64M Sell
8,704
-16
-0.2% -$11.9K 1.78% 21
2025
Q2
$6.8M Hold
8,720
2.19% 14
2025
Q1
$7.2M Buy
8,720
+1,487
+21% +$1.24M 2.53% 7
2024
Q4
$5.58M Buy
+7,233
New +$5.99M 1.97% 17

Other funds holding LLY

First Washington Corp's LLY Position: Q1 2026 in Review

First Washington Corp reduced its Eli Lilly (LLY) stake by 0.29% in Q1 2026, selling an estimated $25.3K and leaving 8,602 shares worth $7.91M. The position accounts for 2.24% of the portfolio, ranked #14.

First Washington Corp first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $9.27M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • First Washington Corp held 8,602 shares of Eli Lilly worth $7.91M as of Q1 2026.
  • First Washington Corp sold 25 Eli Lilly shares in Q1 2026, an estimated $25.3K.
  • Eli Lilly made up 2.24% of First Washington Corp's portfolio in Q1 2026, its #14 holding.
  • First Washington Corp first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • First Washington Corp's Eli Lilly position peaked at $9.27M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on First Washington Corp's 13F filing for Q1 2026, filed 14 May 2026.